ADGM

Adagio Medical Holdings Inc

Jul 17 • 02:07PM ET

1.53

Dollar change +0.08
Percentage change 5.52	%

Healthcare • Medical Devices • USA • NASD

Peers: BSX STXS EW LXRX NVRO CUTR BLFS CLPT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-11.04	Insider Own	1.81%	Shs Outstand	15.38M	Perf Week	-12.57%
Market Cap	23.53M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	15.10M	Perf Month	35.40%
Enterprise Value	29.15M	PEG	-	EPS next Q	-	Inst Own	75.37%	Short Float	0.97%	Perf Quarter	72.14%
Income	-74.74M	P/S	40.57	EPS this Y	-	Inst Trans	64.23%	Short Ratio	0.07	Perf Half Y	73.37%
Sales	0.58M	P/B	1.90	EPS next Y	-	ROA	-295.04%	Short Interest	0.15M	Perf YTD	45.71%
Book/sh	0.81	P/C	1.82	EPS next 5Y	-	ROE	-329.16%	52W High	11.57 -86.78%	Perf Year	-86.76%
Cash/sh	0.84	P/FCF	-	EPS past 3/5Y	-143.50% -816.44%	ROIC	-243.29%	52W Low	0.62 144.80%	Perf 3Y	-85.32%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-449.39%	Volatility	9.51% 10.85%	Perf 5Y	-
Dividend TTM	-	EV/Sales	50.26	EPS Y/Y TTM	-4.40%	Oper. Margin	-5822.92%	ATR (14)	0.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.51	Sales Y/Y TTM	2115.38%	Profit Margin	-12975.00%	RSI (14)	56.86	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	2.89	EPS Q/Q	95.12%	SMA20	7.23%	Beta	0.11	Target Price	-
Payout	-	Debt/Eq	1.50	Sales Q/Q	-100.00%	SMA50	18.08%	Rel Volume	0.02	Prev Close	1.45
Employees	80	LT Debt/Eq	1.48	Earnings	-	SMA200	-2.29%	Avg Volume	2.06M	Price	1.53
IPO	Feb 26, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	23,763	Change	5.52%

May-15-25 04:05PM	Adagio Medical Reports First Quarter 2025 Results (Business Wire)
May-07-25 08:30AM	Adagio Medical to Present at the BofA Securities 2025 Health Care Conference (Business Wire)
Apr-17-25 08:30AM	Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System (Business Wire) +92.81%
Mar-31-25 04:01PM	Adagio Medical Appoints Deborah Kaster as Chief Business Officer (Business Wire) -14.36%
08:30AM	Adagio Medical Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
04:01PM	Loading…
Mar-17-25 04:01PM	Adagio Medical Provides Clinical and Business Updates (Business Wire) -7.41% -9.00%
Feb-28-25 08:30AM	Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation (Business Wire) -45.94%
Feb-18-25 04:01PM	Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference (Business Wire)
Dec-16-24 08:00AM	Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director (Business Wire) -9.41%
Nov-14-24 04:01PM	Adagio Medical Reports Third Quarter 2024 Results (Business Wire) +57.87% -19.14%
Nov-04-24 04:01PM	Adagio Medical to Present at the Stifel 2024 Healthcare Conference (Business Wire) +7.75%
Oct-24-24 08:30AM	Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System (Business Wire)
Oct-07-24 04:01PM	Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias (Business Wire) -7.14%
Aug-19-24 04:01PM	Adagio Medical Provides Business Updates (Business Wire)

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in Laguna Hills, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADGM

Adagio Medical Holdings Inc

Upgrade your FINVIZ experience